Patent Portfolio

Method for producing natural killer cells

Ref. No. AJ315
Appl. No.
(filing date)
PCT/JP2026/014931(2026/4/10)
Pub. No.
(Pub. date)
WO2026/216630(2026/10/15)
Priority claim No.
(Priority date)

JP2025-065947(2025/04/11)

Inventor SAITO Megumu, et al.
Assignee Kyoto University
Title of Invention Method for producing natural killer cells
Abstract

The present invention relates to a method for producing natural killer (NK) cells or their progenitor cells. More specifically, it relates to a method for producing CD16-negative lineage cells or CD16-positive lineage cells, which includes a step of selecting cells from a cell population containing NK cells or their progenitor cells, using the expression intensity of CD117 as an indicator.

Comments

The present invention enables the active, selective induction of either CD16-negative or CD16-positive NK cell lineages by intervening in the initial fate-determination process at the hematopoietic progenitor cell stage—specifically, by manipulating the differentiation lineage.

Tag